| Field | Specification |
|---|---|
| Target | |
| Alternative names | Collagen alpha-1 (III) chain; COL3A1 |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | E. coli-derived human Collagen III/COL3A1 recombinant protein (Position: D1222- E1455). |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Clone 9H9 is a mouse monoclonal antibody that recognizes collagen alpha-1(III) chain (gene COL3A1) in human, mouse and rat samples and is validated for Western blot and IHC. The predicted molecular weight is 138.6 kDa, and the supplier reports an observed band at about 180–190 kDa.
Collagen α1(III) chain (COL3A1) forms type III collagen, a fibrillar collagen that occurs with type I collagen in skin, blood vessels and hollow organs. It supports tissue elasticity and strength, and COL3A1 mutations cause vascular Ehlers-Danlos syndrome; it is also studied in wound healing and fibrosis.
| Target | Collagen alpha-1(III) chain (gene COL3A1; UniProt P02461, human) |
|---|---|
| Clone | 9H9 |
| Host / Clonality / Isotype | Mouse / Monoclonal / Mouse IgG2b |
| Reactivity | Human, Mouse, Rat |
| Form | Lyophilized |
| Formulation | Per vial: 4 mg trehalose; 0.9 mg NaCl; 0.2 mg Na2HPO4; 0.05 mg NaN3 |
| Calculated MW | 138.6 kDa |
| Observed MW | 180–190 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.1–0.5 µg/mL |
|---|---|
| IHC (paraffin sections) | 0.5–1 µg/mL |
Samples with a confirmed band (WB): human placenta tissue, HeLa cells, rat heart tissue, mouse heart tissue.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 50 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human intestinal cancer tissue, human mammary cancer tissue, human lung cancerr tissue, mouse intestine tissue, rat intestine tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Immunogen
Recombinant human Collagen III/COL3A1 fragment (Asp1222–Glu1455), expressed in E. coli.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Lin Zhang et al. (2024) Exosomal miRNA reprogramming in pyroptotic macrophage drives silica-induced fibroblast-to-myofibroblast transition and pulmonary fibrosis. Journal of Hazardous Materials. 10.1016/j.jhazmat.2024.136629
Chenfeng Qiao et al. (2025) Ruthenium Oxide Nanozyme for Tendinopathy Treatment via Countering Ferroptosis. Advanced Healthcare Materials. 10.1002/adhm.202501035
Han Lu et al. (2024) 3D bioprinting of a dermal scaffold for full-thickness skin tissue regeneration. Bio-Design and Manufacturing. 10.1631/bdm.2400058
Meng Li et al. (2024) A heparin-functionalized bioink with sustained delivery of vascular endothelial growth factor for 3D bioprinting of prevascularized dermal constructs. International Journal of Biological Macromolecules. 10.1016/j.ijbiomac.2024.130075
Deshuang Meng et al. (2024) Exosomes Derived from Antler Mesenchymal Stem Cells Promote Wound Healing by miR-21-5p/STAT3 Axis. International Journal of Nanomedicine. 10.2147/IJN.S481044
Huang Bangrui et al. (2024) Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway. Natural Products and Bioprospecting. 10.1007/s13659-024-00446-y
Xuebin Shen et al. (2025) Combination Treatment of Timosaponin BII and Pirfenidone Attenuated Pulmonary Fibrosis Through Anti-Inflammatory and Anti-Fibrotic Process in Rodent Pulmonary Fibrosis Model and Cellular Epithelial–Mesenchymal Transition Model. Molecules. 10.3390/molecules30081821
Wenlin Tai et al. (2019) Rapamycin attenuates the paraquat-induced pulmonary fibrosis through activating Nrf2 pathway. Journal of Cellular Physiology. 10.1002/jcp.29094
Pei-pei Fang et al. (2020) ASK1 Enhances Angiotensin II-Induced Liver Fibrosis In Vitro by Mediating Endoplasmic Reticulum Stress-Dependent Exosomes. Mediators of Inflammation. 10.1155/2020/8183713
Ma Yu-kun et al. (2024) Microrna363-5p targets thrombospondin3 to regulate pathological cardiac remodeling. Molecular and Cellular Biochemistry. 10.1007/s11010-024-05125-7
